The effect of long-acting injectable antipsychotics on QRISK3 in patients with bipolar disorder and schizophreniaEUROPEAN PSYCHIATRYIF6.72023-07-190OAAI
Evaluation of the staging after the first manic episode in patients with bipolar disorderEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72021-12-010PREAI
Modafinil increases the number of hypomanic symptoms in patients with bipolar depressive symptoms?EUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72021-12-010PRE
Comparison of clinical and biochemical features between bipolar patients on mood stabilizer alone or combination treatmentEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72019-12-010PREAI
Evaluation of the recurrence rates after the first manic episode: one year follow-up studyEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72019-01-010PREAI